Dr (MD) Helena Radbruch
Charité - University Medicine Berlin, Germany
Presentation
BMBF-Forschungsverbund: SERIMM - Serotonin und Immunmodulation in M/CFS
Dr Helena Radbruch is a junior research group leader and resident at the Department of Neuropathology at Charité - University Medicine Berlin, Germany. After obtaining her doctoral degree at the Institute of Neuroimmunology at Charité, she worked as a postdoctoral fellow and resident at Cecile Vogt Clinic for Neurology Charité followed by a posting as a clinical scientist at the Clinic for Neurology and Clinic for Psychiatry. Dr Radbruch is a principal investigator of the "Serotonin and immunomodulation in ME/CFS (SERIMM)" research network, funded by the Federal Ministry of Education and Research (BMBF), which aims to provide evidence of an altered metabolism of the neurotransmitter serotonin in ME/CFS. Her work within the project includes characterising clinical cohorts and analysing human biosamples using methods such as single-cell sequencing and immunophenotyping to better understand the pathophysiology of tissue and immune system changes in ME/CFS.